Interview with Slawa Troubniakov, Head of Sustainability
Across our diverse portfolio of drug delivery technologies, innovation is motivated by the idea of achieving optimal benefit for patients and our partners.
The LTS Christmas Market 2024
Our employees were able to enjoy the Christmas Market and donate for our charity partners: Hoffnungswerk and Hospizverein Koblenz.
LTS – Our first product in recycled folding boxes
LTS have taken a major step towards product sustainability. Starting in December of this year, we will finally be delivering our first product in recycled folding boxes.
Apple harvest for a good cause – sustainability meets social engagement
A few weeks ago, a special charity team event took place on our LTS apple orchard
There are no barriers to working with us, only opportunities
The breadth of solutions available to our customers today ensures that LTS Device Technologies delivers customized solutions - all underpinned by the LTS purpose of We CARE. We CREATE. We DELIVER.
LTS Lohmann Therapie-Systeme AG: Successful Giving Week 2024 – A Commitment to Sustainability and Community Impact
We believe that sustainability extends beyond the environment. It includes fostering social impact and supporting the communities that surround us.
LTS LOHMANN Therapie-Systeme AG (“LTS”) and Grand River Aseptic Manufacturing (“GRAM”) proudly announce their strategic alliance focused on the sterile fill finish for containers used in LTS’ Sorrel™ wearable injector devices
LTS and Grand River Aseptic Manufacturing to Form Strategic Alliance for Sterile Fill-Finish of Sorrel™ Wearable Injector Containers.
Revolutionizing Drug Delivery with UV Sterilization Technology
This article delves into the benefits and challenges of prefilled and preloaded drug delivery systems and highlights Sorrel™’s pioneering efforts in this field.
LTS honored as one of Germany’s Best Managed Companies 2024
We are pleased to announce that we have been awarded as a Best Managed Company 2024.
LTS Inaugurates a New Semi-automated Commercial Production Line and Announces Global Manufacturing to Support SorrelTM Wearable Device Market Expansion
LTS today announced the successful commercial validation of a semi-automated production line for the Sorrel™ wearable drug delivery platform.